Search for European Projects

37 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Join the Europe Experience

Start date: Jun 1, 2016, End date: May 31, 2018,

...cts, our Life Science business delivers many of the most highly-respected brands in the industry, such as Millipore, Milli-Q, SAFC and BioReliance. Our offering covers every step of the biotech production chain, creating a complete end-to-end workflow with enhanced customer service, a simplified interface and a leading distribution platform. Our innovative portfolio, well-balanced geographic reach ...
Read Project

 10

 FINISHED 
...’s (including NIH) in a LEAN process. It will also be valued by an elaborate Market & Stakeholder Advisory Committee, existing of Business Developers of 20-35 important pharmaceutical, medtech, biotech companies and Venture Capitalists. Thus here, valorisation of Health results will not be enhanced by just pushing harder, but by defragmenting and presenting these results in a way that the market w ...
Read Project

 11

 FINISHED 
... joint activities within ScanBalt Bioregion in knowledge formation and innovation and to increase the visibility of these actions. An important feature of ScanBalt Campus is that despite its focus on Biotech/life sciences, all activities should reflect a holistic view. This means that the educational training should also encompass a broad view on societal activities.ScanBalt Campus: Knowledge form ...
Read Project

 31

 FINISHED 

FIN-EST start-up development programme (FINESTstartups)

Start date: Apr 30, 2011, End date: Aug 30, 2013,

...tes to the development and competitiveness of the programme area. The project helps creative and ambitious entrepreneurial people with bright business ideas in different fields (IT, gaming industry, biotech, medicine, energy, creative economy, social entrepreneruship, etc) to form their ideas into real and successful international business. Both in Estonia and Finland lots of people with good b ...
Read Project

 5

 FINISHED 
FASILIS will open up public and private research infrastructures in the field of human health (biotech. pharmaceutical and medical technology) to SMEs from other regions in NWE. The aim is to give SMEs access to a far wider range of research facilities than is currently available at a regional level. broadening the competence networks of both SMEs and research infrastructures and so contributing s ...
Read Project

 6

 FINISHED 
...he project, to South Sweden (2012 Lund/Malmö) as one of the leading life science regions in Europe, and US-West Coast 2013 (San Francisco Bay Area; Los Angeles) as one of the outstanding US biotech clusters. Both study tours were planned to gain insight into successful international clusters, on how they work and to exchange experiences. By the project partners, a total of 27 regional workshops we ...
Read Project

 3

 FINISHED 

Clusters & Cities Network (CLUSNET)

Start date: Sep 30, 2008, End date: Dec 30, 2011,

...ster is currently too focused on public funding and should strive for stronger private engagements. By the end of November 2009, the CLUSNET team met in Leipzig for a seminar focusing on the Leipzig Biotech cluster into which the city has invested greatly. On the basis of the policy exchanged, the CLUSNET team suggested: 1) The cluster suffers from a lack of private industry involvement. 2) Also, ...
Read Project

 12

 FINISHED 
The project will bring mutual transfer of knowledge between partners to help synergic capacity building in biomedical research as well as contribution to the development of research and intellectual infrastructure of both sides whose improvement is essential for lasting and sustainable co-operation. Translating research into internationally marketable products can directly add momentum to the regi ...
Read Project

 2

 FINISHED 
... of charge (only a login is required). Comprehensive materials were developed download-friendly and the flexibility of the eLSi platforms makes it accessible to various stakeholders: pharma, medtech, biotech and healthcare managers, VETs, incl. business consultants, culture and language service providers, cluster/business support organisations.
Read Project

 6

 FINISHED 
...ithin and outside Europe are therefore impossible to avoid. A miscommunication originating from the cultural differences may however create complex problems. To address this issue, the Young European Biotech Network (YEBN) and its Institutional Members ASSB (Poland), btS (Germany), Club Biotech (Austria), FEBiotec (Spain) and NGB (France) offer a Training Course on "Intercultural Communication Amo ...
Read Project

 6

 FINISHED 

BK Hilden goes Europe

Start date: Jun 1, 2014, End date: May 30, 2015,

... in European countries, in order to reinforce their linguistic, inter-cultural and professional skills and knowledge. The 37 participants of the project belong to different sections: 2-year-course in biotech, 3-year-course in IT and students of commercial education. Before attending Berufskolleg Hilden these students decided to work in very different professional areas and have reached different q ...
Read Project

 26

 FINISHED 

Higher education student and staff mobility project

Start date: Jun 1, 2014, End date: May 31, 2016,

The project 2014-2016 is the first project that Sup'Biotech benefited from. The goal of our belongng to the Erasmus + Program is to give the opportunuty to our students to benefit from a mobility inside Europe and have access to an Erasmus Grant at the same time. Sup'Biotech sent 12 students to 6 different destinations. They all benefited from the pretigious education given in our partner univers ...
Read Project

 1

 FINISHED 

ADDY: Addicted to Europe – Competences through Mobility

Start date: Sep 1, 2014, End date: Aug 31, 2016,

C & Q Bildungszentrum Haberhauffe GmbH is a vocational training provider from Berlin. For over 20 years C & Q offers practice-oriented further qualification in growth industries (Biotech and Life Sciences, Energy and Environment, Knowledge and Content Management, Personality and Society, Knowledge and Organization, Occupational Health and Safety). Furthermore C & Q provides clients with comprehens ...
Read Project

 2

 FINISHED 

Teaching biotechnology for human health: from the bench to the market

Start date: Dec 22, 2014, End date: Jun 21, 2017,

Graduate programmes in Medical Biotechnology have their foundations in providing scientific knowledge and related technical skills, to be applied in research or professional laboratories. Existing MSc/DSc courseworks are poorly homogeneous with no attitude to serve as a bridge between Industry and Academia. Medical biotechnology has been a major industrial sector in expansion during the 21st cent ...
Read Project

 7

 FINISHED 

Technicians in Europe

Start date: Jun 1, 2015, End date: May 31, 2017,

...tes in European countries, in order to reinforce their linguistic, inter-cultural and professional skills and knowledge. The participants of the project belong to different sections: 2-year-course in biotech and 3-year-course in IT. Before attending Berufskolleg Hilden these students decided to work in very different professional areas and have reached different qualifications and certificates. Th ...
Read Project

 11

 FINISHED 
ETB-PRO will reduce the fragmentation of ERA and support high quality R&D&I project cooperation of European biotech SMEs by building on success factors of the predecessor project and establish a sustainable joint program with high funding impact. This will be done in two steps thereby using four calls with a funding volume of € 35 Mio each as an implementation tool. First step: Integration ETB-PRO ...
Read Project

 16

 FINISHED 
...ho controls development and other options and (b) empirical investigation (secondment at LUISS) of multi-stage R&D and IP licensing deals (viewed as compound real options), applied to a proprietary biotech/pharma licensing deals database. This is of interest to European policymakers and in line with King’s and MIT’s innovation- and policy-oriented strategy connecting research to business and socie ...
Read Project

 1

 FINISHED 

Drug CandIdates ScreenINg (DeCISIoN)

Start date: Jul 1, 2016, End date: Jun 30, 2018,

Pluriomics is an international Dutch/Belgian biotech company specialised in developing stem cell-based assays for cardiac safety pharmacology and drug discovery and development. Pluriomics developed a unique proprietary protocol to differentiate heart muscle cells derived from human induced pluripotent stem cells (hiPSCs). The company provides its customers with reliable cell technology systems to ...
Read Project

 1

 FINISHED 
Meeting demand for sustainable plant-based protein is set to be a crucial challenge for future food security. For that reason NapiFeryn BioTech (www.napiferyn.pl) aims to develop and commercialize technologies for the isolation of nutritional components from plant sources and in particular from legumes, cereals and oilseeds. To do so, co-founders rely on their extensive international experience, g ...
Read Project

 1

 FINISHED 

European Marine Biology Resource Centre preparatory phase 2 (pp2EMBRC)

Start date: Oct 1, 2015, End date: Sep 30, 2016,

EMBRC is a distributed infrastructure of marine biology and ecology, encompassing aquaculture and biotechnology, exploiting the latest “omics”, analytical and imaging technologies, and providing on site and remote scientific and technical services to the scientific community of the public and private sector. EMBRC successfully completed a preparatory phase in early in 2014 with the production of a ...
Read Project

 16

 FINISHED 
... likely would lead to increased survival.Therefore, this project has the potential to lead to a reduced mortality of gastric cancer, and it will also add significantly to European research and to the biotech industry."
Read Project

 1

 FINISHED 
...ive expertises in a complementary synergism to reach the objectives proposed. Horus Pharma, a French pharmaceutical company, specialised on production, distribution and sales of pharmaceutical and biotech products for eye therapy and diagnostic; and Bioftalmik, a Spanish company specialised on biomarker discovery and development of medical devices for ophthalmology applications.This project is cr ...
Read Project

 2

 FINISHED 

UROthelial carcinoma Biomarker based diagnostic tEST (URO-BEST)

Start date: May 1, 2015, End date: Sep 30, 2015,

... and superior to other existing molecular diagnostic products (Urovysion, NMP22, BTA Stat). We estimate the current market for bladder cancer biomarker based tests at greater than > $200million. Fina Biotech has filed European and PCT patent applications protecting the invention in 2013.Fina Biotech aims to clinically validate the diagnostic performance of the genetic signatures in patients under ...
Read Project

 1

 FINISHED 
...clic peptide-drug chimeras) and bacterial killing (both planktonic and biofilms). INPACT includes four leading academic partners (from Portugal, Spain, Australia, and Brazil) and three consolidated biotech SMEs (one from Portugal and two Spain).In addition to the R&D project itself, INPACT involves at the highest possible level a top business school in Europe (IESE, Barcelona, Spain), a consolidat ...
Read Project

 8

 FINISHED 
...ronment. In a tailor-made training program BIOCASCADES aims to provide the nine early stage researchers with specific scientific and transferable skills for careers in the highly dynamic European biotechnology sector. Training at leading laboratories of biocatalysis will develop their scientific skills, while secondments to the industry and specific workshops will develop their entrepreneurship. T ...
Read Project

 12

 FINISHED 

SYSTEMS GLYCOBIOLOGY OF GASTRIC CANCER (GASTRICGLYCOEXPLORER)

Start date: May 1, 2013, End date: Apr 30, 2018,

...way for developing bioinformatics, databases, software, bioanalysis, reagents and biomolecule synthesis/production. These resources are now in use throughout the life science environment in academia, biotech and biopharma. However, there is no individual institute to our knowledge that can prepare new systems glycobiologists for the full impact of the environment they will operate in. This ITN is ...
Read Project

 13

 FINISHED 
This proposal has three major strands to it: (i) The return of Prof Olsen from seven years of work experience in two of the major US plant Biotech companies (Pioneer Hi-Bred International, a DuPont Company and the Monsanto Company) to head up a research project and further develop strategic plans for plant research at the Norwegian University for Biosciences and Hamar University College, (ii) a sp ...
Read Project

 1

 FINISHED 
"This program encompasses the coordinated action of three major Biomedicine Research Centers and a Biotech shell in Lombardy, to launch a new Structured International Post-Doctoral program (SIPOD). These research centers operate in conjunction with the Scuola Europea di Medicina Molecolare (SEMM) whose aim is to promote the training and research of young scientists within emerging sectors of biome ...
Read Project

 4

 FINISHED 

European Consortium for Microbial Resource Centres (EMbaRC)

Start date: Feb 1, 2009, End date: Sep 30, 2012,

...ervices will enable the development of new partnerships with public institutes in the field of biodiversity and will facilitate revenue-generating partnerships with the economic sector (large food or biotech companies, research organisations, SMEs, NGO’s etc) that will be defined in a set of validate business models for Biological Resource Centres. The objective is to enable not only the EMbaRC pa ...
Read Project

 10

 FINISHED 
Many HIV vaccine concepts and several efficacy trials have been conducted in the prophylactic and therapeutic fields with limited success. There is an urgent need to develop better vaccines and tools predictive of immunogenicity and of correlates of protection at early stage of vaccine development to mitigate the risks of failure. To address these complex and challenging scientific issues, the Eur ...
Read Project

 43

 FINISHED 

European Prevention of Alzheimer’s Dementia Consortium (EPAD)

Start date: Jan 1, 2015, End date: Dec 31, 2019,

Background:The secondary prevention of Alzheimer’s dementia (AD) is achievable if we can identify individuals at risk of disease progression defined by biomarker evidence of AD pathology and no or only minimal clinical symptoms and engage them in a standing adaptive clinical trial, of the highest quality, testing multiple interventions. To achieve this, EPAD will also provide the analytical infras ...
Read Project

 40

 FINISHED 
Scientific understanding of the role and mechanisms of bioactives is fragmented. Research often addresses the theoretical possibility of health improvement effects rather than their real, practical use for everyday diets. Bioactives cannot be considered as discrete chemical compounds and research must focus on bioactive-enriched foods (BEF), if consumer demands for foods delivering appropriate hea ...
Read Project

 28

 FINISHED 

Scaffolds for alternative delivery (SADEL)

Start date: Jan 1, 2012, End date: Dec 31, 2016,

The SME-based SADEL consortium intends to develop the first generation of oral bio-therapeutics tackling disease targets in the digestive tract, by making optimal use of the Nanofitin (Nf) protein scaffold. Nf based drugs will progress through routes not travelled by antibodies while interacting with targets not modulated by chemical compounds.Existing Nf hits against validated targets will progre ...
Read Project

 10

 FINISHED 

Mucus Permeating Nanoparticulate Drug Delivery Systems (ALEXANDER)

Start date: Apr 1, 2012, End date: Mar 31, 2016,

The objective of the ALEXANDER project is the identification of novel strategies (e.g., proteolytic enzyme strategy, thiomer strategy, zeta potential changing systems, SNEDDS strategy) and the optimization of existing strategies (e.g., disulfide breaking strategy and slippery surface strategy) for the efficient transport of nanocarriers through the mucus gel layer (e.g., intestinal, nasal, ocular, ...
Read Project

 20

 FINISHED 

Development of antibiofilm coatings for implants (COATIM)

Start date: Jan 1, 2012, End date: Dec 31, 2015,

"The aim of the SME-driven COATIM consortium is to tackle the increasing problem of infections due to biofilms, groups of microorganisms that stick together on different surfaces within the human body and escape conventional antibiotic treatment. Biofilms are typically found on medical devices like implants. The most recent generation of implants with open porosity enable fast osseointegration, bu ...
Read Project

 11

 FINISHED 
Vaccine development is an empirical process (trial and error) and involves a long, expensive clinical development pipeline to license an efficacious vaccine candidate. Better tools for vaccine evaluation are needed to adapt to a rising number of candidate vaccines entering clinical trials for many diseases. Surrogate biomarkers of immunity offer the possibility of expediting the clinical developme ...
Read Project

 8

 FINISHED 
Mosquitoes transmit a variety of infectious diseases that cause a tremendous burden to public health. Due to climate changes and to the increase in international trade and tourism the threats posed by mosquitoes are increasingly affecting large parts of Europe, causing understandable concerns among the populations of many Member States. Control methods, mainly based on insecticide usage, are strug ...
Read Project

 31